NOS3 polymorphisms do not associate with adverse clinical outcomes in elderly hypertensives with coronaryartery disease: Analysis of the international verapamil SR-trandolapril study genetic substudy (invest-genes).

被引：0
|
作者：
Pacanowski, M. A. [1 ]
Zineh, I. [1 ]
Welder, G. J. [1 ]
Adicks, J. [1 ]
Cooper-DeHoff, R. M. [1 ]
Pepine, C. J. [1 ]
Johnson, J. A. [1 ]
机构：
[1] Univ Florida, Gainesville, FL 32611 USA
来源：
CLINICAL PHARMACOLOGY & THERAPEUTICS | 2008年 / 83卷
关键词：
D O I：
暂无
中图分类号：
R9 [药学];
学科分类号：
1007 ;
摘要：
引用
收藏
页码：S83 / S83
页数：1
相关论文
共 10 条
  • [1] Cacnaic polymorphisms and cardiovascular outcomes in the international verapamil SR/trandolapril study-genetic substudy (invest-genes).
    Navare, H. A.
    Beitelshees, A. L.
    Gong, Y.
    Langaee, T. Y.
    Cooper-Dehoff, R. M.
    Pepine, C. J.
    Johnson, J. A.
    CLINICAL PHARMACOLOGY & THERAPEUTICS, 2008, 83 : S4 - S4
  • [2] α-Adducin polymorphism associated with increased risk of adverse cardiovascular outcomes:: Results from GENEtic Substudy of the INternational VErapamil SR-trandolapril STudy (INVEST-GENES)
    Gerhard, Tobias
    Gong, Yan
    Beitelshees, Amber L.
    Mao, Xianyun
    Lobmeyer, Maximilian T.
    Cooper-DeHoff, Rhonda M.
    Langaee, Taimour Y.
    Schork, Nicholas J.
    Shriver, Mark D.
    Pepine, Carl J.
    Johnson, Julie A.
    AMERICAN HEART JOURNAL, 2008, 156 (02) : 397 - 404
  • [3] Genetic Variation in the β2 Subunit of the Voltage-Gated Calcium Channel and Pharmacogenetic Association With Adverse Cardiovascular Outcomes in the INternational VErapamil SR-Trandolapril STudy GENEtic Substudy (INVEST-GENES)
    Niu, Yuxin
    Gong, Yan
    Langaee, Taimour Y.
    Davis, Heather M.
    Elewa, Hazem
    Beitelshees, Amber L.
    Moss, James I.
    Cooper-DeHoff, Rhonda M.
    Pepine, Carl J.
    Johnson, Julie A.
    CIRCULATION-CARDIOVASCULAR GENETICS, 2010, 3 (06) : 548 - 555
  • [4] β2-adrenergic receptor polymorphisms and antihypertensive treatment outcomes in the international verapamil SR/trandolapril study-genetic substudy (invest-genes).
    Pacanowski, M. A.
    Gong, Y.
    Langaee, T. Y.
    Cooper-DeHoff, R. M.
    Schork, N. J.
    Pepine, C. J.
    Johnson, J. A.
    CLINICAL PHARMACOLOGY & THERAPEUTICS, 2007, 81 : S34 - S34
  • [5] Liver x receptor-α gene variability and cardiovascular risk in the international verapamil SR/trandolapril study -: Genetic substudy (invest-genes).
    Price, E. T.
    Martin, M.
    Pacanowski, M.
    Cooper-Dehoff, R. M.
    Pepine, C. J.
    Johnson, J. A.
    Zineh, T.
    CLINICAL PHARMACOLOGY & THERAPEUTICS, 2008, 83 : S66 - S66
  • [6] Diabetes risk associated with beta 1-adrenergic receptor polymorphisms differs by antihypertensive drug therapy: Results from the international verapamil SR/trandolapril study - Genetic substudy (invest-genes).
    Pacanowski, M. A.
    Cooper-DeHoff, R. M.
    Gong, Y.
    Schork, N. J.
    Pepine, C. J.
    Johnson, J. A.
    CLINICAL PHARMACOLOGY & THERAPEUTICS, 2008, 83 : S83 - S83
  • [7] Pulse pressure and risk of cardiovascular outcomes in patients with hypertension and coronary artery disease: an INternational VErapamil SR-trandolapril STudy (INVEST) analysis
    Bangalore, Sripal
    Messerli, Franz H.
    Franklin, Stanley S.
    Mancia, Giuseppe
    Champion, Annette
    Pepine, Carl J.
    EUROPEAN HEART JOURNAL, 2009, 30 (11) : 1395 - 1401
  • [8] Risk of adverse cardiovascular outcomes and new diabetes with combination therapy in hypertensive patients with coronary artery disease: the INternational VErapamil SR-Trandolapril STudy (INVEST)
    Mancia, G
    Keltai, M
    Erdine, S
    Hewkin, A
    Kupfer, S
    Pelpine, CJ
    EUROPEAN HEART JOURNAL, 2004, 25 : 423 - 424
  • [9] NON-SYNONYMOUS SNPS IN SELE, SELP, AND SIGLEC12 ASSOCIATE WITH CARDIOVASCULAR (CV) OUTCOMES IN THE INTERNATIONAL VERAPAMIL SR-TRANDOL-APRIL STUDY GENETIC SUBSTUDY (INVEST-GENES)
    McDonough, C. W.
    Burkley, B.
    Gong, Y.
    Langaee, T. Y.
    Pepine, C. J.
    Cooper-DeHoff, R. M.
    Johnson, J. A.
    CLINICAL PHARMACOLOGY & THERAPEUTICS, 2012, 91 : S20 - S21
  • [10] DNA Variations In Voltage-gated Calcium Channel Beta 2 Subunit (CACNB2) Gene, Functional Consequences, and Association with Adverse Cardiovascular Outcomes In the INternational VErapamil SR-trandolapril STudy-GENEtic Substudy
    Niu, Yuxin
    Langaee, Taimour Y.
    Gong, Yen
    Moss, James I.
    Cooper-Dehoff, Rhonda M.
    Pepine, Carl J.
    Johnson, Julie A.
    CIRCULATION, 2008, 118 (18) : S885 - S885
1